Famotidine
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 18 |
Source: | Health Canada |
---|
Side effects: | 18 |
Source: | Health Canada |
---|
Side effects: | 28 |
Source: | Health Canada |
---|
Side effects: | 39 |
Source: | medicines.org.au |
---|
Side effects: | 52 |
Source: | medicines.org.au |
---|
Side effects: | 44 |
Source: | FDA Structured Product Label |
---|
Side effects: | 45 |
Source: | FDA Structured Product Label |
---|
Side effects: | 49 |
Source: | FDA |
---|
Side effects: | 48 |
Source: | FDA |
---|
Side effects: | 49 |
Source: | FDA |
---|
Side effects: | 50 |
Source: | FDA |
---|
Side effects: | 51 |
Source: | FDA |
---|
Side effects: | 54 |
Source: | FDA Structured Product Label |
---|
Side effects: | 55 |
Source: | FDA Structured Product Label |
---|
Side effects: | 55 |
Source: | FDA Structured Product Label |
---|
Side effects: | 56 |
Source: | FDA Structured Product Label |
---|
Side effects: | 52 |
Source: | FDA Structured Product Label |
---|
Side effects: | 54 |
Source: | FDA Structured Product Label |
---|
Side effects: | 53 |
Source: | FDA Structured Product Label |
---|
Side effects: | 53 |
Source: | FDA Structured Product Label |
---|
Side effects: | 54 |
Source: | FDA Structured Product Label |
---|
Side effects: | 54 |
Source: | FDA Structured Product Label |
---|
Side effects: | 55 |
Source: | FDA Structured Product Label |
---|
Side effects: | 56 |
Source: | FDA Structured Product Label |
---|
Side effects: | 51 |
Source: | Health Canada |
---|
Side effects: | 59 |
Source: | Health Canada |
---|
Side effects: | 85 |
Source: | Health Canada |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|